Location · Denver, CO
Clinical trials in Denver, CO
493 recruiting studies have a site in the Denver area, and 165 of them accept healthy volunteers. The area includes Aurora, Lakewood, Englewood, Littleton, Centennial, Lone Tree and nearby cities.
493 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Los Angeles, CA + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Rhythm Pharmaceuticals, Inc.
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Dimerix Bioscience Pty Ltd
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 12–80
- RecruitingPhase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Alebund Pharmaceuticals
- Location
- Granada Hills, CA + 17 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Neurona Therapeutics
- Location
- Little Rock, AR + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
ReGenTree, LLC
- Location
- Laguna Hills, CA + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Medicure
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
BioRestorative Therapies
- Location
- Santa Monica, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 2
Study With Phage for CF Subjects With Pseudomonas Lung Infection
BiomX Ltd
- Location
- Birmingham, AL + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
GIE Medical
- Location
- Scottsdale, AZ + 32 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical
- Location
- Scottsdale, AZ + 30 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 1/Phase 2
A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.
Ashibio Inc
- Location
- Denver, CO
- Eligibility basics
- Ages 18–89
- Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Kardion Inc
- Location
- Chandler, AZ + 16 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 1/Phase 2
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
Splice Bio
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 12–65
- Recruiting
Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries
Regenexx, LLC
- Location
- Broomfield, CO
- Eligibility basics
- Ages 18–65
- Recruiting
Trial for Treating Painful Degenerative Disc Disease
Regenexx, LLC
- Location
- Broomfield, CO + 1 other US site
- Eligibility basics
- Ages 25–65
- RecruitingPhase 2
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Denver, CO + 3 other US sites
- Eligibility basics
- Ages 16+
- Recruiting
Freedom-1 Study for Chronic Knee Pain
Curonix LLC
- Location
- Placentia, CA + 12 other US sites
- Eligibility basics
- Ages 18+